8:00–8:30 a.m.
Breakfast & Registration
8:30–9:30 am
Welcome & Keynote Presentation:
Biotech State of the World
G. Steven Burrill, CEO, Burrill & Company
9:30–10:30 am
Panel: Life Science Progress/Problems in the Pacific Northwest
- Karimah Es Sabar, President, Life Sciences British Columbia
- Jack Faris, President, Washington Biotechnology & Biomedical Association
- Matt Gardner, President & CEO, Baybio
- Bob Lanier, Executive Director, Oregon Bioscience Association
Moderated by:
David Almodovar, Vice President, Credit Suisse
Zack Scott, Director, Burrill & Company
10:30–10:45 am
Break
10:45 a.m.–12:15 pm
Company Presentations
- Blacktoe Medical, Ron Schutz, President & CEO
- Dimera, Theresa L. Thompson, Research Director
- Electrical Geodesics, Ann Bunnenberg, President
- Floragenex, Nathan Lillegard, President & CEO
- Molecular MD, Stephane Wong, COO
- Vesticon, Cathryn Epley, President & CEO
12:15–1:15 pm
Networking Lunch
1:15–1:45 pm
Presentation: Stimulating the Life Science Industry in Oregon
State Senator Ben Westlund, Oregon
1:45–3:00 pm
Panel: Success Stories in the Pacific Northwest
- Adolph Ferro, President & CEO, Artielle Imunotherapeutics
- Sri Nagalla, EVP & CSO, ProteoGenix
- Richard A. Sessions, CEO, Znomics
- Dean Sproles, President & CEO, Iverson Genetic Diagnostics, Inc.
- Mike Wright, President & CEO, Wellpartner
Moderated by:
John Hamer, Managing Director, Burrill & Company
3:00–3:15 pm
Break
3:15–4:30 pm
Panel: Capital Markets and Capital Market Availability for Pacific Northwest Companies in Today’s Markets
- Giovanni Ferrara, Managing Director, Burrill & Company
- Bill Newman, Managing Director, Northwest Technology Ventures
- Sam Nickerson, Vice President, Tullis-Dickerson & Co.
- Carl Weissman, President & CEO, Accelerator Corporation
Moderated by:
Martin F. Medeiros, Partner, Swider Medeiros Haver LLP
4:30–5:00 pm
2020 Vision for Biotech and How It Applies to The Pacific Northwest – What’s Next...
G. Steven Burrill, CEO, Burrill & Company
5:00–7:00 pm
Networking Reception
